Back to Search
Start Over
Determining which patients with myelodysplastic syndrome will respond to immunosuppressive treatment.
- Source :
-
Haematologica [Haematologica] 2006 May; Vol. 91 (5), pp. 583-4. - Publication Year :
- 2006
- Subjects :
- Adult
Age Factors
Aged
Autoimmune Diseases complications
Autoimmune Diseases drug therapy
Autoimmune Diseases genetics
Blood Transfusion
Chromosomes, Human, Pair 8
Etanercept
HLA-DR Antigens analysis
Humans
Immunoglobulin G therapeutic use
Middle Aged
Multicenter Studies as Topic
Myelodysplastic Syndromes complications
Myelodysplastic Syndromes genetics
Myelodysplastic Syndromes immunology
Pancytopenia drug therapy
Pancytopenia etiology
Predictive Value of Tests
Prognosis
Receptors, Tumor Necrosis Factor therapeutic use
T-Lymphocytes
Treatment Outcome
Trisomy
Tumor Necrosis Factor-alpha antagonists & inhibitors
Antilymphocyte Serum therapeutic use
Cyclosporine therapeutic use
Immunosuppressive Agents therapeutic use
Myelodysplastic Syndromes drug therapy
Patient Selection
Subjects
Details
- Language :
- English
- ISSN :
- 1592-8721
- Volume :
- 91
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- Haematologica
- Publication Type :
- Editorial & Opinion
- Accession number :
- 16670061